Week Ending November 1, 2021

Targeted High-Dose Radiation Helps Fight Advanced Lung Cancer
“High-dose radiation therapy may stall tumor growth in patients with advanced lung cancer who are not fully responding to drug therapies, a preliminary study suggests.”

Addressing Disparities in Lung Cancer From a Geographic Perspective
“To address these disparities, he emphasized the need for a comprehensive, proactive approach to corrective interventions, highlighted innovative solutions to the problem of inequity in care, and identified social policy interventions as the best way to make improvements.”

November is Lung Cancer Awareness Month – Here’s What You Need to Know About Screenings
“With November being National Lung Cancer Month, it’s a good time to bring awareness to a crucial task for the public. To be screened for lung cancer.”

Scientists Learn More about How Lung Cancer Becomes Resistant to Drugs
“For people with lung cancer, drug resistance is the major cause of relapse. A tumor might respond very well at first — maybe even shrinking down to an undetectable level — only to develop resistance and grow back.”

Perseverance and Endurance in the Face of Lung Cancer
“The second annual Lung Cancer Heroes® awards program provides us another opportunity to recognize incredible people who nurture hope and cultivate fortitude.”

Lung cancer patients fight stigma as more non-smokers are diagnosed
“Terry Morey was surprised to find himself out of breath one day in 2013 while going for a walk on his acreage near Cochrane.”

Toxicity Management Remains Key With Expanding Frontline Treatment Options in Lung Cancer
“Best practices for managing treatment-related toxicities with frontline targeted therapy and immunotherapy is still being determined in patients with lung cancer, said Antoinette Wozniak, MD, FACP, FASCO.”

New Finding Could Predict Which People with Lung Cancer Will Benefit from Chemotherapy
“Lung adenocarcinoma, the most common form of lung cancer in the United States, can be difficult to cure unless diagnosed at an early stage. Surgery is effective at removing early-stage tumors, but more than half of patients with stage 2 or 3 disease have a recurrence of their cancer elsewhere in the body.”

UNMC Lung Cancer Study Shows Better Outcomes for More Serious Forms of Disease
“The results of a year-long lung cancer study by researchers at the University of Nebraska Medical Center suggest earlier screening could save lives. The data shows an increased five-year survival rate for people who had more serious forms of lung cancer.”

It’s Not a Small World for Small Cell Lung Cancer Treatment

Targeted Therapies in Non-Small Cell Lung Cancer

Exciting movement happening in KRAS-mutated lung cancer treatments